Cattle tick vaccine in Australia proving successful in trials

Published Jun 19, 2024

Tridge summary

A vaccine developed at the University of Queensland has shown high efficacy in early trials against cattle ticks, a significant pest for the Australian beef industry. Created by Professor Ala Tabor's lab at UQ's Centre for Animal Science after 18 years of research, the vaccine disrupts the tick's life cycle and reduces egg viability. Current chemical treatments are unsustainable and face resistance issues. Supported by an Australian Economic Accelerator Seed Grant, the vaccine is now in a proof-of-concept trial on 30 cows, aiming for commercial adoption. Early funding came from Meat and Livestock Australia, the University of Queensland, the Beef CRC, and the Queensland government.
Disclaimer: The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

UQ's Dr Hannah Siddle and Professor Ala Tabor in the laboratory. Picture supplied by UQ A vaccine developed at the University of Queensland has proven highly effective in early trials to address one of the country's top cattle pests. Dr Hannah Siddle, from the Queensland Alliance for Agriculture and Food Innovation said the cattle tick vaccine was created by the Tabor laboratory at UQ's Centre for Animal Science after more than 18 years of research. "Professor Ala Tabor led small trials of the vaccine that have shown promising efficacy and we are now moving to larger trials," Dr Siddle said. "The Australian beef industry loses $128 million a year because of cattle ticks, and when you look globally, those costs swell into the many billions. "The parasite causes loss of condition in the animal and the ticks also carry and transmit potentially fatal diseases. "The beauty of this vaccine is that it protects the cattle from the effects of tick feeding and breaks the life cycle of any ...
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.